Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
α-Mangostin is one of the main active constituents that can be isolated from the stem bark of Garcinia malaccensis (GM) and has been documented to exert different cytotoxic activities against many cancerous cell lines. Due to its non selective distribution into the tissue, this study had attempted t...
| Main Authors: | , , |
|---|---|
| Format: | Proceeding Paper |
| Language: | English |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/12374/ http://irep.iium.edu.my/12374/1/IPBS_poster_%25282%2529.pdf |
| _version_ | 1848777433559334912 |
|---|---|
| author | Elsaid Ali, Aimen Abdo Bakhtiar, M. Taher Mohamed, Farahidah |
| author_facet | Elsaid Ali, Aimen Abdo Bakhtiar, M. Taher Mohamed, Farahidah |
| author_sort | Elsaid Ali, Aimen Abdo |
| building | IIUM Repository |
| collection | Online Access |
| description | α-Mangostin is one of the main active constituents that can be isolated from the stem bark of Garcinia malaccensis (GM) and has been documented to exert different cytotoxic activities against many cancerous cell lines. Due to its non selective distribution into the tissue, this study had attempted to encapsulate the α-mangostin into biodegradable PLGA copolymer using colloidal extraction solvent evaporation method. The polysaccharide Chitosan was incorporated with the loaded nanoparticles to improve their affinity towards lung cancer cells. The resultant nanoparticles were characterized for their size distribution and external morphology by laser diffractometry and scanning electron microscope (SEM), respectively. The concentration of entrapped α-mangostin was determined by HPLC. Our data demonstrated that the encapsulation efficiency for Chitosan-α-mangostin-loaded PLGA nanoparticles (CM-NP) was higher than those without Chitosan (M-NP). The in vitro release from (CM-NP) and (NPM) was carried out in PBS containing 0.1% tween 20 over three weeks. Whereas, in vitro anti-cancer activities of (CM-NP) and (M-NP) were evaluated against lung cancer cell line (A549) and compared to the free α-mangostin. Our data revealed that (CM-NP) showed higher cytotoxic effect compared to (M-NP) and both had lower cytotoxicity than free α-mangostin. In conclusion, PLGA nanoparticles in combination with Chitosan may be used as a promising composite micro-carrier system to deliver α-mangostin to the lung cancer tissue.
|
| first_indexed | 2025-11-14T14:45:55Z |
| format | Proceeding Paper |
| id | iium-12374 |
| institution | International Islamic University Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T14:45:55Z |
| publishDate | 2011 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | iium-123742014-12-09T01:31:46Z http://irep.iium.edu.my/12374/ Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent Elsaid Ali, Aimen Abdo Bakhtiar, M. Taher Mohamed, Farahidah RM300 Drugs and their action RS Pharmacy and materia medica α-Mangostin is one of the main active constituents that can be isolated from the stem bark of Garcinia malaccensis (GM) and has been documented to exert different cytotoxic activities against many cancerous cell lines. Due to its non selective distribution into the tissue, this study had attempted to encapsulate the α-mangostin into biodegradable PLGA copolymer using colloidal extraction solvent evaporation method. The polysaccharide Chitosan was incorporated with the loaded nanoparticles to improve their affinity towards lung cancer cells. The resultant nanoparticles were characterized for their size distribution and external morphology by laser diffractometry and scanning electron microscope (SEM), respectively. The concentration of entrapped α-mangostin was determined by HPLC. Our data demonstrated that the encapsulation efficiency for Chitosan-α-mangostin-loaded PLGA nanoparticles (CM-NP) was higher than those without Chitosan (M-NP). The in vitro release from (CM-NP) and (NPM) was carried out in PBS containing 0.1% tween 20 over three weeks. Whereas, in vitro anti-cancer activities of (CM-NP) and (M-NP) were evaluated against lung cancer cell line (A549) and compared to the free α-mangostin. Our data revealed that (CM-NP) showed higher cytotoxic effect compared to (M-NP) and both had lower cytotoxicity than free α-mangostin. In conclusion, PLGA nanoparticles in combination with Chitosan may be used as a promising composite micro-carrier system to deliver α-mangostin to the lung cancer tissue. 2011 Proceeding Paper PeerReviewed application/pdf en http://irep.iium.edu.my/12374/1/IPBS_poster_%25282%2529.pdf Elsaid Ali, Aimen Abdo and Bakhtiar, M. Taher and Mohamed, Farahidah (2011) Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent. In: International Postgraduate Conference on Biotechnology (IPBC) 2011, 15-18 Dec 2011, Kuala Terengganu. http://imb.umt.edu.my/ipcb2011/ |
| spellingShingle | RM300 Drugs and their action RS Pharmacy and materia medica Elsaid Ali, Aimen Abdo Bakhtiar, M. Taher Mohamed, Farahidah Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent |
| title | Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
|
| title_full | Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
|
| title_fullStr | Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
|
| title_full_unstemmed | Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
|
| title_short | Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
|
| title_sort | development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent |
| topic | RM300 Drugs and their action RS Pharmacy and materia medica |
| url | http://irep.iium.edu.my/12374/ http://irep.iium.edu.my/12374/ http://irep.iium.edu.my/12374/1/IPBS_poster_%25282%2529.pdf |